Back

Standard versus extended dual antiplatelet therapy after pci in acute coronary syndrome: a systematic review and meta-analysis

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Personalising antithrombotic therapy in percutaneous coronary intervention for acute coronary syndromes: balancing ischaemic protection and bleeding risk Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Alejandro Gasca

Cali (Colombia)

5 More presentations in this session

Presentation thumbnail
Impact of intravascular imaging guidance on the effects of aspirin-free strategy for percutaneous coronary intervention for acute coronary syndrome: a post-hoc analysis from the STOPDAPT-3 trial
Doctor K. Takabayashi (Shiga, JP)
Abstract Slides
Presentation thumbnail
Temporal trends in the use of P2Y12 inhibitors over 15 years and their impact on in-hospital bleeding and mortality among patients with acute myocardial infarction in Switzerland
Mr J. Loosli (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of routine cardiovascular medications on contrast induced nephropathy post percutaneous coronary intervention: a national experience
Doctor O. Alameen (Doha, QA)
Abstract Slides
Presentation thumbnail
Timing of P2Y12 inhibitor administration in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis
Doctor T. Theodoropoulou (Athens, GR)
Abstract Slides
Presentation thumbnail
Early aspirin withdrawal to P2Y12 monotherapy after PCI for ACS: a systematic review and meta-analysis of randomized controlled trials
Professor M. Saffi (Porto Alegre, BR)
Abstract Slides

Access the full session

Session thumbnail
Personalising antithrombotic therapy in percutaneous coronary intervention for acute coronary syndromes: balancing ischaemic protection and bleeding risk

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
27 August 2022
thumbnail
Webinar
Antithrombotic strategy for ACS: from default to alternative strategies. ESC 2023 Clinical Practice Guidelines - Webinar Series
28 November 2023
thumbnail
Congress Presentation
Prognostic impact of ventricular arrhythmia timing in acute coronary syndromes treated with percutaneous coronary intervention: a systematic review and meta-analysis
14 April 2026
thumbnail
Congress Presentation
Statin and DAPT use for post-ACS patients during covid-19 pandemic: changing perspectives of Indian practitioners
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources